![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Perabo Frank Müller Stefan
Publisher: Informa Healthcare
ISSN: 0036-5599
Source: Scandinavian Journal of Urology and Nephrology, Vol.39, Iss.2, 2005-04, pp. : 108-116
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of superficial bladder cancer with intravesical chemotherapy: an update
By Witjes J.A. Mungan N.A. Debruyne F.M.J.
Urology, Vol. 56, Iss. 1, 2000-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metastatic Bladder Cancer: Role of Chemotherapy and New Agents
EAU Update Series, Vol. 1, Iss. 2, 2003-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer
By Katz G. Hackett R.L. Wajsman Z.
Urology, Vol. 47, Iss. 6, 1996-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)